港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

高瓴概念

464.136

-1.938-0.42%

漲家數：17

跌家數：32

平家數：6

市盈率：- -

高：466.909

開：465.076

低：457.555

收：466.075

資料載入中...

總覽新聞資訊

和鉑醫藥－Ｂ(02142)股價上升5.238%，現價港幣$8.64

阿斯达克财经

港股異動 | 榮昌生物(09995)績前漲超6% 多項成果入選2025 ASCO口頭報告泰它西普三期MG數據積極

榮昌生物盤中異動股價大漲5.06%

君實生物早盤漲逾3% 一季度歸母淨虧損同比收窄17%

《股市簡訊》君實生物中港股齊升4.3%，一季度淨虧同比減少

心通醫療-B盤中異動早盤急速下跌5.38%報0.880港元

機構：被動醫藥基金份額、規模達到歷史最高值，港股創新藥ETF盤中反彈跌幅收窄，君實生物等超3%

21世纪经济报道

復星醫藥(02196.HK)附屬組合夥投資醫療器械診斷

阿斯达克财经

三生製藥盤中異動早盤急速跳水9.37%報11.800港元

雲頂新耀-B盤中異動大幅下挫5.27%

翰森製藥盤中異動早盤股價大跌3.35%報23.100港元

德琪醫藥-B盤中異動股價大跌6.35%

美團－Ｗ(03690)出現大手買入4.36萬股，成交價$127.35，涉資555.246萬

阿斯达克财经

中國鐵塔取得一種出賬加速方法及裝置專利

歸創通橋-B擬繼續進行H股購回計劃並將購回H股的最高金額調整至不超過6.5億港元

【特約大V】郭家耀：市場觀望情緒疊加長假期臨近整體成交有所減少

雲頂新耀：移除股份“B”標記業績高增長

2025 AACR | 信達生物多項創新雙抗、三抗及雙抗ADC臨牀前數據亮相

雲頂新耀宣佈於5月2日起正式從股份簡稱中移除“B”

百濟神州因受限制股份單位獲歸屬發行2.93萬股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1583/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":464.1363,"timestamp":1745825025764,"preClose":466.07452,"halted":0,"volume":537835663,"delay":0,"changeRate":-0.004159,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-1.938232,"latestTime":"04-28 15:23:46","open":465.0756,"high":466.90872,"low":457.55487,"amount":13413805399,"amplitude":0.020069,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1745827800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745803800000,1745812800000],[1745816400000,1745827200000]],"pbRate":2.234092,"peRate":21.950815,"turnoverRate":0.003941,"increases":17,"decrements":32,"flats":4,"marketCap":2616525899776,"floatMarketCap":2049131396608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":466.90872,"amplitude":0.020069,"preClose":466.07452,"low":457.55487,"pbRate":"2.234092","latestPrice":464.1363,"volume":537835663,"delay":0,"open":465.0756,"prevYearClose":446.93042,"prevWeekClose":466.075,"prevMonthClose":505.776,"prevQuarterClose":505.776,"fiveDayClose":463.703,"twentyDayClose":499.551,"sixtyDayClose":446.618,"secType":"PLATE","market":"HK","turnoverRate":0.003941,"peRate":21.950815,"marketCap":2616525899776,"floatMarketCap":2049131396608,"timestamp":1745825025764,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":17,"down":32,"flat":6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530049750","title":"和鉑醫藥－Ｂ(02142)股價上升5.238%，現價港幣$8.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2530049750","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530049750?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 10:25","pubTimestamp":1745807100,"startTime":"0","endTime":"0","summary":"[上升股]和铂医药－Ｂ(02142) 股价在上午10:25比前收市价上升5.238%，现股价为港币$8.64。至目前为止，今日最高价为$8.64，而最低价为$7.85。总成交量为306.6万股，总成交金额为港币$2.517千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR250428589/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1583","02142","BK1161"],"gpt_icon":0},{"id":"2530349285","title":"港股異動 | 榮昌生物(09995)績前漲超6% 多項成果入選2025 ASCO口頭報告 泰它西普三期MG數據積極","url":"https://stock-news.laohu8.com/highlight/detail?id=2530349285","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530349285?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 10:19","pubTimestamp":1745806779,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荣昌生物绩前涨超6%，截至发稿，涨6.1%，报46.1港元，成交额3.26亿港元。消息面上，美国临床肿瘤学会2025年年会将于5月30日至6月3日在美国芝加哥举行。国泰海通证券指出，RC48联合疗法1L胃癌纳入2025 ASCO口头汇报，看好其治疗潜力。gMG 预计25年中获批，有望参与25年医保。该行预计公司2026年经营性现金流转正，看好公司长期发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1064131003.USD","IE0031619046.USD","IE00B19Z4B17.USD","IE00B7SZL793.SGD","688331","BK1583","LU2148510915.USD","LU1064130708.USD","BK1574","09995","IE00B66KJ199.SGD","LU2328871848.SGD","BK0239","BK1161","LU1969619763.USD","BK4123","MG"],"gpt_icon":0},{"id":"2530923074","title":"榮昌生物盤中異動 股價大漲5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530923074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530923074?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 10:15","pubTimestamp":1745806524,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘10时15分，荣昌生物股票出现异动，股价大幅上涨5.06%。截至发稿，该股报45.650港元/股，成交量677万股，换手率3.57%，振幅9.90%。荣昌生物股票所在的生物技术行业中，整体跌幅为1.66%。其相关个股中，中国抗体-B、创胜集团-B、荣昌生物涨幅较大，振幅较大的相关个股有中国抗体-B、云康集团、创胜集团-B，振幅分别为13.74%、12.71%、10.00%。该信息摘要如下：荣昌生物获上百家机构调研，关注其核心管线开发进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428101524aa2c7c5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428101524aa2c7c5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","09995","BK1574","LU1969619763.USD","LU2328871848.SGD","BK1161"],"gpt_icon":0},{"id":"2530249254","title":"君實生物早盤漲逾3% 一季度歸母淨虧損同比收窄17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530249254","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530249254?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 10:15","pubTimestamp":1745806500,"startTime":"0","endTime":"0","summary":"　　君实生物绩后涨超3%，截至发稿，股价上涨2.59%，现报15.82港元，成交额2641.64万港元。　　4月25日，君实生物公布2025年第一季度业绩，营业收入约5亿元，同比增长31.46%。归属于上市公司股东的净亏损约2.35亿元，同比收窄17%。与此同时，公司积极落实“提质增效重回报”行动方案，提升销售效率，并将资源聚焦于更具潜力的研发项目，与上年同期相比亏损减少。截至报告期末，公司的货币资金及交易性金融资产余额合计30.22亿元，资金储备较为充足。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-28/doc-ineustca2159099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01877","BK0239","BK1161","BK1583","BK1515","688180"],"gpt_icon":0},{"id":"2530494357","title":"《股市簡訊》君實生物中港股齊升4.3%，一季度淨虧同比減少","url":"https://stock-news.laohu8.com/highlight/detail?id=2530494357","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530494357?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 10:11","pubTimestamp":1745806295,"startTime":"0","endTime":"0","summary":"《股市简讯》君实生物中港股齐升4.3%，一季度净亏同比减少* 中国生物科技公司--君实生物A股688180.SS周一早盘一度升4.3%，其H股1877.HK涨4.3%，一季度净亏同比减少。* 恒生香港上市生物科技指数.HSHKBIO盘中至多跌3.8%。* 君实生物上周五公布，一季度净亏损同比减亏，营收增逾三成，得益于核心产品销售收入增加、销售效率提升等。（完）\n        更多股市简讯请点选CN-CMN-HOT (发稿 崔珠珠；审校 林高丽) ((zhuzhu.cui@thomsonreuters.com; +86-21-20830048;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4T3R604C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877","688180","BK1583","BK0239","BK1161","BK1515"],"gpt_icon":0},{"id":"2530491796","title":"心通醫療-B盤中異動 早盤急速下跌5.38%報0.880港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530491796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530491796?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 10:03","pubTimestamp":1745805781,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘10时03分，心通医疗-B股票出现波动，股价急速下跌5.38%。截至发稿，该股报0.880港元/股，成交量119.4万股，换手率0.05%，振幅4.30%。资金方面，该股资金流入1.44万港元，流出98.494万港元。心通医疗-B股票所在的医疗设备及用品行业中，整体涨幅为0.08%。其相关个股中，堃博医疗-B、心泰医疗、中国卫生集团涨幅较大，振幅较大的相关个股有堃博医疗-B、康沣生物-B、心泰医疗，振幅分别为15.92%、14.22%、13.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428100301aa2c7c54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428100301aa2c7c54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02160","BK1100","BK1583"],"gpt_icon":0},{"id":"2530249175","title":"機構：被動醫藥基金份額、規模達到歷史最高值，港股創新藥ETF盤中反彈跌幅收窄，君實生物等超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530249175","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530249175?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 10:01","pubTimestamp":1745805712,"startTime":"0","endTime":"0","summary":"4月28日，港股医药板块低开低走，盘中触底反弹，港股创新药ETF一度跌超4%，现跌幅收窄至2.5%以内，多只成分股翻红，君实生物、荣昌生物、凯莱英超3%。消息面上，恒瑞医药拟发行H股获得中国证监会备案。从基金份额上看，主动医药基金份额为1246亿份，环比减少152亿份。因此主动药基规模的提升，主要系股价上升。被动医药基金份额为2662亿元，环比提升412亿份，达到历史最高值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042810063494e53d1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042810063494e53d1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01877","688180","BK1161","BK1583"],"gpt_icon":0},{"id":"2530349452","title":"復星醫藥(02196.HK)附屬組合夥投資醫療器械診斷","url":"https://stock-news.laohu8.com/highlight/detail?id=2530349452","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530349452?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 09:54","pubTimestamp":1745805240,"startTime":"0","endTime":"0","summary":"复星医药(02196.HK) 公布，附属复星平耀与上海复健、控股股东复星高科技及复曜智港签订合伙协议，拟共同设立河南复健，分别以现金出资490万、10万、290万、210万元人民币，权益占比分别为49%、1%、29%、21%。复星医药指，为加强大健康产业的布局，拟参与发起设立以中原地区为中心，以医疗器械诊断、生命科学、创新药及其上下游产业链为主要投资方向的股权投资基金。河南复健设立后，拟作为发起设立该股权投资基金的普通合伙人。(ha/a)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-25 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220221174704291_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220221174704291_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1436237/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09997","09996","BK0239","BK0183","159883","BK1191","BK0187","BK1593","BK0096","BK1222","BK0028","BK0196","BK0188","BK1515","02196","BK1583","600196","BK0060","BK0012","BK1574","BK0175","BK1100"],"gpt_icon":0},{"id":"2530999704","title":"三生製藥盤中異動 早盤急速跳水9.37%報11.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530999704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530999704?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 09:39","pubTimestamp":1745804375,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘09时39分，三生制药股票出现波动，股价快速跳水9.37%。截至发稿，该股报11.800港元/股，成交量2153.9万股，换手率0.90%，振幅7.07%。三生制药股票所在的药品行业中，整体跌幅为0.43%。其相关个股中，四环医药、海王英特龙、金嗓子涨幅较大，振幅较大的相关个股有三生制药、东阳光长江药业、翰森制药，振幅分别为7.07%、6.56%、6.07%。减持后其最新持股数目约为 1248.66 万股，最新持股比例为 0.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093935a469c1d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093935a469c1d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1593","01530","BK1161"],"gpt_icon":0},{"id":"2530991574","title":"雲頂新耀-B盤中異動 大幅下挫5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530991574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530991574?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 09:36","pubTimestamp":1745804182,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘09时36分，云顶新耀-B股票出现波动，股价大幅下挫5.27%。云顶新耀-B股票所在的生物技术行业中，整体跌幅为2.50%。消息层面，截至09时36分，《云顶新耀：移除股份“B”标记 业绩高增长》资讯为影响云顶新耀-B的重要信息。云顶新耀作为沪深港通下港股通标的，此次股份简称“B”标记的移除，表明公司在市值和收入等达主板上市企业要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093622a469c07c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093622a469c07c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","01952","BK1161"],"gpt_icon":0},{"id":"2530499174","title":"翰森製藥盤中異動 早盤股價大跌3.35%報23.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530499174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530499174?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 09:36","pubTimestamp":1745804177,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘09时36分，翰森制药股票出现异动，股价快速跳水3.35%。截至发稿，该股报23.100港元/股，成交量111.2万股，换手率0.02%，振幅6.07%。资金方面，该股资金流入598.69万港元，流出1637.5万港元。翰森制药股票所在的药品行业中，整体跌幅为0.43%。其相关个股中，四环医药、海王英特龙、金嗓子涨幅较大，振幅较大的相关个股有三生制药、翰森制药、东阳光长江药业，振幅分别为7.07%、6.07%、5.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093617a469c071&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093617a469c071&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","03692","BK1583"],"gpt_icon":0},{"id":"2530499434","title":"德琪醫藥-B盤中異動 股價大跌6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530499434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530499434?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 09:31","pubTimestamp":1745803891,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘09时31分，德琪医药-B股票出现异动，股价大幅跳水6.35%。德琪医药-B股票所在的药品行业中，整体跌幅为0.42%。其相关个股中，四环医药、海王英特龙、康龙化成涨幅较大，振幅较大的相关个股有东阳光长江药业、石药集团、三生制药，振幅分别为4.26%、3.76%、3.69%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093131aa2c7c39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093131aa2c7c39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","BK1574","06996"],"gpt_icon":0},{"id":"2530499334","title":"美團－Ｗ(03690)出現大手買入4.36萬股，成交價$127.35，涉資555.246萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2530499334","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530499334?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 09:30","pubTimestamp":1745803800,"startTime":"0","endTime":"0","summary":"[大手成交]美团－Ｗ(03690)在上午09:30出现大手买入，成交量为4.36万，成交价为港币$127.35，涉资555.246万。至目前为止，股价跌0.47%，今日最高价为$128.0，而最低价为$127.0，总成交量为186.935万股，总成交金额港币$2.388亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT25042847/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00B031HY20.USD","LU0039217434.USD","LU1323998911.USD","LU0588545904.SGD","LU1831875114.USD","IE0008369823.USD","BK1142","LU0164872284.USD","LU0611395673.USD","LU1720050803.USD","LU0214875030.USD","BK1583","03690","LU0605514214.HKD","LU0823426480.USD","IE00BPRC5H50.USD","LU0700851271.USD","LU1794554557.SGD","LU0149721374.USD","LU0501845795.SGD","LU1242518857.USD","LU1868837722.USD","MPNGY","LU2778985437.USD","BK1233","LU0181495838.USD","LU2476274308.USD","LU0594300179.USD","BK1575","LU0048597586.USD","LU0165289439.USD","LU0449509016.USD","LU0499858602.USD","LU0633140560.USD","BK1618","LU0594300419.USD","LU1102505762.USD","LU0067412154.USD","LU1868837565.USD","IE00B3M56506.USD","LU0211977185.USD","IE00B5MMRT66.SGD","LU0823040885.USD","LU0541502299.USD","LU0456846285.SGD","LU0348816934.USD","HMTD.SI","LU0348735423.USD","LU1675838814.USD","BK1610"],"gpt_icon":0},{"id":"2530962464","title":"中國鐵塔取得一種出賬加速方法及裝置專利","url":"https://stock-news.laohu8.com/highlight/detail?id=2530962464","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530962464?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 08:58","pubTimestamp":1745801914,"startTime":"0","endTime":"0","summary":"金融界2025年4月28日消息，国家知识产权局信息显示，中国铁塔股份有限公司取得一项名为“一种出账加速方法及装置”的专利，授权公告号 CN 114090686 B ，申请日期为 2021 年 11 月 。天眼查资料显示，中国铁塔股份有限公司，成立于2014年，位于北京市，是一家以从事土木工程建筑业为主的企业。企业注册资本1760084.7102万人民币。通过天眼查大数据分析，中国铁塔股份有限公司共对外投资了4家企业，参与招投标项目5000次，财产线索方面有商标信息181条，专利信息695条，此外企业还拥有行政许可76个。本文源自：金融界作者：情报员","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428090315a6caf054&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428090315a6caf054&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1506","LU0823413660.USD","BK1521","BK1589","IE00BHRH8D16.HKD","LU0823413587.USD","00788","BK1181","BK1529","02943","IE00BG0RBZ43.SGD","IE00BHRH8C09.USD","BK1583","BK1133","BK1190"],"gpt_icon":0},{"id":"2530499193","title":"歸創通橋-B擬繼續進行H股購回計劃 並將購回H股的最高金額調整至不超過6.5億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530499193","media":"新浪网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530499193?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 08:31","pubTimestamp":1745800309,"startTime":"0","endTime":"0","summary":"归创通桥-B公布，董事会决定继续进行H股购回计划，并鉴于公司 H股价格持续上涨，议决将购回H股的最高金额调整至不超过6.5亿港元。董事会进一步宣布，于公司于2024年6月6日举行的2023年股东周年大会上批准的购回授权届满后，待于公司应届2024年股东周年大会上批准新购回授权，公司决定根据新购回授权继续不时于公开市场购回H股。该购回须待取得中华人民共和国有关监管机构就股份购回的外汇汇款批准后方可落实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504280847179747c0ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504280847179747c0ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1587","BK1574","02190","BK1100"],"gpt_icon":0},{"id":"2530460486","title":"【特約大V】郭家耀：市場觀望情緒疊加長假期臨近 整體成交有所減少","url":"https://stock-news.laohu8.com/highlight/detail?id=2530460486","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530460486?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 08:28","pubTimestamp":1745800099,"startTime":"0","endTime":"0","summary":"投资者继续观望贸易战消息，加上长假期临近，整体成交有所减少，北水亦录得净流出情况，预料指数继续于21,500至22,500点水平上落。行业消息中国铁塔日前公布第一季业绩，整体增长稳健，公司实现营业收入247.71亿元人民币，同比增长3.3%；EBITDA为172.95亿元人民币，增长4.2%；归属于本公司股东的利润达30.24亿元人民币，增长8.6%。整体而言，中国铁塔的业务发展势头良好，前景可期。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/ZjliN2ZkODRiNzhhNzU2YzM1OTEzZDg3ZjhhMTI3MDQ3NzI4ODg1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZjliN2ZkODRiNzhhNzU2YzM1OTEzZDg3ZjhhMTI3MDQ3NzI4ODg1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1957746","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU0823413587.USD","IE00BHRH8C09.USD","BK1583","00788","BK1589","LU0823413660.USD","BK1133","BK1529","IE00BHRH8D16.HKD","IE00BG0RBZ43.SGD","BK1506"],"gpt_icon":0},{"id":"2530932564","title":"雲頂新耀：移除股份“B”標記 業績高增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2530932564","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530932564?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 08:03","pubTimestamp":1745798625,"startTime":"0","endTime":"0","summary":"【4 月 28 日，云顶新耀宣布重大变动！】2025 年 4 月 28 日，云顶新耀是专注创新药研发等的生物制药公司。其已满足港交所上市规则第 8.05 条的市值/收益要求，股份简称中的“B”标记于 2025 年 4 月 22 日获批移除，相关变更自 2025 年 5 月 2 日生效。云顶新耀作为沪深港通下港股通标的，此次股份简称“B”标记的移除，表明公司在市值和收入等达主板上市企业要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042809100694e52a7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042809100694e52a7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01952","BK1161","BK1583"],"gpt_icon":0},{"id":"2530460589","title":"2025 AACR | 信達生物多項創新雙抗、三抗及雙抗ADC臨牀前數據亮相","url":"https://stock-news.laohu8.com/highlight/detail?id=2530460589","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530460589?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 08:00","pubTimestamp":1745798400,"startTime":"0","endTime":"0","summary":"很高兴在本次AACR年会上国清院展示多项临床前研究成果，包括多个全球首创的双抗、多抗及ADC的首次亮相，这不仅展现了我们的研发实力，也进一步坚定了我们在全球范围内为患者提供突破性治疗选择的信心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4673771_ZH73771_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4080","BK4231","LU2488822045.USD","01801","BK1589","LU1969619763.USD","BK1161","LU2328871848.SGD","ADC","BK1583"],"gpt_icon":0},{"id":"2530462350","title":"雲頂新耀宣佈於5月2日起正式從股份簡稱中移除“B”","url":"https://stock-news.laohu8.com/highlight/detail?id=2530462350","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530462350?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 07:38","pubTimestamp":1745797130,"startTime":"0","endTime":"0","summary":"中国上海—2025年4月28日—云顶新耀是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司，今日宣布，公司已满足香港联交所上市规则第8.05条的市值/收益要求，其股份简称中的“B”标记于2025年4月22日获得批准移除，相关变更将自2025年5月2日起正式生效。云顶新耀作为沪深港通下港股通标的，股份简称“B”标记的成功移除，标志着公司在市值和收入等方面已达到主板上市企业要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/28073849934308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK1161","01952","BK1574"],"gpt_icon":0},{"id":"2530464976","title":"百濟神州因受限制股份單位獲歸屬發行2.93萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530464976","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530464976?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 07:16","pubTimestamp":1745795764,"startTime":"0","endTime":"0","summary":"格隆汇4月28日丨百济神州(06160.HK)发布公告，2025年4月26日，因根据股权计划授出的受限制股份单位获归属(公司董事除外)而发行2.93万股普通股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428071604a6cada84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428071604a6cada84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","LU0588546209.SGD","BK1583","LU2328871848.SGD","BK1500","BK1588","BK1161","LU1969619763.USD","LU0307460666.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":44,"pageCount":2,"totalSize":864,"code":"91000000","status":"200"}]}}